Dr. Mark Edward Ranson, MD

Dr. Ranson practices at Adventhealth Diabetes Institute Orlando - HOPD in Orlando, Florida.

Dr. Ranson's NPI, 1790990687, was assigned on May 14, 2007. Dr. Ranson graduated from West Virginia University School Of Medicine in 2001. Dr. Ranson holds Florida license ME97969.

Dr. Ranson's primary practice is Adventhealth Diabetes Institute Orlando - HOPD, at 2415 N Orange Ave, Orlando, FL 32804.

Dr. Ranson's primary practice is Adventhealth Diabetes Institute Orlando - HOPD in Orlando, Florida. Dr. Ranson is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Ranson to 1 more group practice or clinic and 1 home health agency, each named with a free account. Dr. Ranson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ranson practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Ranson's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Ranson is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Ranson's licenses on file in 3 states: Florida, New York and North Carolina.

Dmand AI lists blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization, peripheral vascular disease and varicose veins among the conditions Dr. Ranson treats.

CMS data shows 1,212 Medicare services from Dr. Ranson across 19 procedure codes in 2024, for 620 Medicare patients. Medicare paid $92,755 for them.

CMS counts 620 Medicare patients who saw Dr. Ranson in 2024. The largest group is 75 to 84, with 241 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ranson's median patient age at 69, with 49% women.

In 2024, Dr. Ranson wrote 201 Medicare Part D claims for 73 patients. 71% of them were for generic drugs. CMS names the drug for 186 of them, across 4 drugs with 11 or more claims each, at $43,595 in total drug cost. In 2023, CMS named 199 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ranson for performance year 2024, reported as part of a group. Dr. Ranson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ranson as offering telehealth. CMS counts 13 procedures of leg revascularization (restoring blood flow) by Dr. Ranson, more than 68% of the clinicians it reports for that procedure.

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Ranson in 2007. The most frequent topics are Blood Vessel Prosthesis Implantation.

Dmand AI links Dr. Ranson to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Penetrating Atherosclerotic Ulcer, Peripheral Arterial Occlusive Disease 1 and Postphlebitic Syndrome.

CMS Open Payments shows 450 general payments to Dr. Ranson from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. AngioDynamics, Inc. paid the most, $5,722.

Dmand AI lists 1 award for Dr. Ranson.

Dr. Ranson graduated from West Virginia University School Of Medicine in 2001. Dr. Ranson is a member of ACS and SVS.

Dr. Ranson is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.